X

Trial Profile

A Phase IIa proof-of-concept study Clinical Trial of 18-MC in individuals undergoing opioid withdrawal

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 30 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zolunicant (Primary)
Indications Opioid-related disorders
Focus Proof of concept; Therapeutic Use
Sponsors Mindmed

Most Recent Events

28 Mar 2022 According to a Mindmed media release, this trial is expected to commence in Q2 2022.
04 Jan 2022 According to a Mindmed media release, this trial is expected to begin in early 2022.
30 Mar 2020 According to a Mindmed media release, the company is targeting to begin its Phase 2 trial of 18-MC by the end of the year

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com